NEURAL SPICING
Financiado
Neural Spectral Image Decoding
Had we the capacity to image the molecular tissue composition in real time, without exposing the patient or clinical staff to radiation, then this would revolutionize healthcare. Spectral imaging techniques, such as multispectral...
Had we the capacity to image the molecular tissue composition in real time, without exposing the patient or clinical staff to radiation, then this would revolutionize healthcare. Spectral imaging techniques, such as multispectral diffuse reflectance imaging and photoacoustics, have the potential to recover important tissue properties including oxygenation, temperature and the concentration of water. However, decades of research invested in solving the inverse problem of reconstructing clinically relevant tissue properties from spectral measurements have failed to produce solutions that can quantify tissue parameters robustly in a clinical setting. Initial attempts to address the limitations of model-based approaches with machine learning were hampered by the absence of labeled reference data needed for supervised algorithm training. While training data simulation can potentially address this bottleneck, the domain gap between real and simulated images remains a huge unsolved challenge.
This project at the intersection of physics, biology, medicine, and data science bridges the domain gap with a learning-to-simulate approach and reframes the quantification problem as a decoding problem that can be tackled with physics-constrained neural networks. It is based on the hypothesis that unlabeled and weakly labeled measurement data can be leveraged to improve the realism of simulated spectral images and ultimately the quantification accuracy. In building upon modern machine learning techniques, the concept naturally allows different sources of uncertainty to be handled and even exploited, requires no labeled data for the target task, and enables imaging systems to learn from their experience. The proposed second generation of spectral imaging is inherently safe and low-cost and could thus pave the way for a new era in interventional healthcare, with clinical applications ranging from cancer diagnosis to the staging and therapy of cardiovascular and inflammatory diseases.
ver más
Duración del proyecto: 60 meses
Fecha Inicio: 2021-04-22
Fecha Fin: 2026-04-30
Fecha Fin: 2026-04-30
Línea de financiación: concedida
El organismo H2020 notifico la concesión del proyecto el día 2021-04-22
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
ERC-2020-COG:
ERC CONSOLIDATOR GRANTS
Cerrada
hace 4 años
Presupuesto
El presupuesto total del proyecto asciende a
2M€
Líder del proyecto
DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG
No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico
TRL
4-5
Perfil tecnológico
TRL
4-5
342.29K€ |
Participante
236.86K€ |
Participante